Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

PURPOSE: The introduction of ligands targeting prostate-specific membrane antigen (PSMA), especially (68)Ga-PSMA-11, has changed the management of patients with prostate cancer (PCa). (18)F-Labelled ligands can be produced in larger amounts and therefore can improve availability for a larger group o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Nucl Med Mol Imaging
Prif Awduron: Rahbar, Kambiz, Afshar-Oromieh, Ali, Seifert, Robert, Wagner, Stefan, Schäfers, Michael, Bögemann, Martin, Weckesser, Matthias
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6182394/
https://ncbi.nlm.nih.gov/pubmed/30027419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4089-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg